İfakat İrem Biçer

Dr. İfakat İrem Biçer

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAli Kirik
Ali Kirik
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Nizameddin KocaNizameddin Koca
Nizameddin Koca
TKTurkan Pasali Kilit
Turkan Pasali Kilit
SSsibel demiral sezer
sibel demiral sezer
TDTeoman Doğru
Teoman Doğru
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.

1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
BABanu Açmaz
Banu Açmaz
SBSami Bahçebaşı
Sami Bahçebaşı
EAErdem Aydın
Erdem Aydın
ŞYŞeyma Yıldız
Şeyma Yıldız
İBİfakat İrem Biçer
İfakat İrem Biçer
Introduction: Obesity, particularly morbid obesity, is associated with significant metabolic alterations such as insulin resistance and compensatory hyperinsulinemia. These pathophysiological changes may influence the performance and interpretation of glycemic diagnostic tools, including the oral glucose tolerance test (OGTT) and glycated hemoglobin (HbA1c). This study is aimed at comparing the diagnostic profiles of OGTT and HbA1c across BMI categories, with a specific focus on morbid obesity and the potential role of elevated insulin levels in test discrepancies. Materials and Methods: This retrospective study included 1031 patients who were classified into nonobese, obese, and morbidly obese groups based on body mass index (BMI). All participants underwent assessment of glycemic status, lipid profile, and related metabolic parameters. Results: Of the study population, 86.8% were female. Based on BMI classification, 56.5% were obese, 35.8% morbidly obese, and 7.8% nonobese. The prevalence of dysglycemia (prediabetes + diabetes) was 43.1% according to HbA1c and 30.9% according to OGTT. Dysglycemia was significantly more frequent in the morbidly obese group by HbA1c ( p < 0.001), while OGTT showed no significant intergroup difference ( p = 0.117). The agreement between methods was low ( κ = 0.326). HbA1c, insulin, HOMA‐IR, CRP, and triglyceride levels increased with BMI. Insulin‐related parameters were higher among HbA1c‐defined dysglycemic individuals. Discussion: HbA1c may be more sensitive in identifying early metabolic disturbances, particularly during the compensatory phase involving hyperinsulinemia. Elevated insulin levels may attenuate glucose response during OGTT, potentially reducing its diagnostic sensitivity.

2 January 2026 in Postgraduate Medicine
Verified
Journal Article
Closed access
BTBurcin Atak Tel
Burcin Atak Tel
İBİfakat İrem Biçer
İfakat İrem Biçer
IBIsil Bavunoglu
Isil Bavunoglu
NONur Düzen Oflas
Nur Düzen Oflas
MTMelisa Sahin Tekin
Melisa Sahin Tekin
SKSelma Karaahmetoglu
Selma Karaahmetoglu
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.

24 February 2025 in Bratislava Medical Journal
Verified
Journal Article
Open access
PDF file
MOMerve Ozcetin
Merve Ozcetin
İBİfakat İrem Biçer
İfakat İrem Biçer
ODOguzhan Dizdar
Oguzhan Dizdar
Objetives: We aimed to examine the effects of newly started SGLT2 inhibitors on thiamine levels. Background: High glucose in the renal tubular epithelium causes increased renal clearance of thiamine. Therefore, we hypothesized that glucosuria induced by SGLT2 inhibitors may result in thiamine deficiency. Methods: The SGLT2 inhibitors group included patients who were added to their treatment with an SGLT2 inhibitor and who did not have glucosuria. The control group comprised patients who were taking medications other than SGLT2 inhibitors. Patients in both groups were followed for three months. Results: The study was completed by 27 patients in each group, with a mean age of 53.2 ± 9.6 years. At baseline, the SGLT2 inhibitors group had worse glycemic control compared to the control group (p < 0.001), but no difference for thiamine. In the SGLT2 inhibitors group, but not in the control group, there were significant decreases in glucose, HbA1c, and creatinine values at the end of the 3-month follow-up, accompanied by a significant increase in thiamine levels. Conclusion: Glucosuria induced by SGLT2 inhibitors did not lead to a decrease in whole-blood thiamine levels. Whole-blood thiamine levels increased with improved glycemic control. SGLT2 inhibitors demonstrated favourable effects on both glycemic control and creatinine levels.

9 October 2026 in Geriatrik Bilimler Dergisi
Verified
Journal Article
Open access
NBNazmiye Serap Biçer
Nazmiye Serap Biçer
BABanu Açmaz
Banu Açmaz
İBİfakat İrem Biçer
İfakat İrem Biçer
Objective: Insulin resistance (IR) and atherogenic dyslipidemia (AD) are metabolic disturbances strongly associated with cardiometabolic diseases. In recent years, the evidence regarding the associations of IR and AD with skeletal measures and fracture outcomes in older individuals has remained limited and inconsistent. The aim of this study was to evaluate the relationships of insulin resistance indices and atherogenic lipid parameters with bone mineral density measurements and fragility fracture history in men aged 50 years and older and postmenopausal women in the presence of osteopenia or osteoporosis.Materials and Methods: This single-center retrospective cross-sectional study was conducted at Kayseri City Hospital, Türkiye, between January 2025 and December 2025, and included men aged ≥50 years and postmenopausal women who underwent bone mineral density (BMD) measurement for screening purposes. Given the limited reliability of fasting insulin levels in older adults, insulin resistance was evaluated through the Metabolic Score For Insulin Resistance (METS-IR) and the triglyceride-glucose (TyG) index in place of HOMA-IR. Atherogenic dyslipidemia was characterized using triglyceride concentrations, HDL-C, LDL-C, total cholesterol, non-HDL-C, and the non-HDL-C/HDL-C ratio. Dyslipidemia was defined by elevated triglyceride concentrations, reduced HDL-C, or increased LDL-C, according to established thresholds. Fracture history was determined using clinical records and patient self-reports.Results:A total of 150 patients diagnosed with osteopenia or osteoporosis were included in the final analyses; 72.7% were female, and 37.3% had a history of fragility fracture (FF). FF was not associated with hypertension or dyslipidemia; however, it was observed more frequently among participants with a prior history of cerebrovascular events. The TyG index showed no significant association with bone-related parameters, whereas METS-IR demonstrated a significant positive association with femoral T-score and femoral BMD. In addition, individuals with higher METS-IR values also had higher non-HDL cholesterol levels and NHHR. Age was identified as an independent determinant of FF history.Conclusion: In this selected population of men aged 50 years and older and postmenopausal women with osteopenia or osteoporosis, age remained the primary correlate of fragility fracture history. While age remains the primary determinant of fracture risk, METS-IR showed a significant positive association with femoral BMD and femoral T-score in correlation analyses, whereas no comparable association was observed with respect to the TyG. Taken together, these observations highlight that the effects of metabolic disturbances on bone health should not be interpreted as uniform risk factors but rather evaluated within the context of age, body composition, and overall metabolic status.

7 April 2026 in Life
Verified
Journal Article
Open access
PDF file
BABanu Açmaz
Banu Açmaz
SBSami Bahçebaşı
Sami Bahçebaşı
NBNazmiye Serap Biçer
Nazmiye Serap Biçer
İBİfakat İrem Biçer
İfakat İrem Biçer
EAErdem Aydın
Erdem Aydın
GAGokhan Acmaz
Gokhan Acmaz
Aim: Using real-world data from an obesity clinic, we aimed primarily to define the body composition phenotype associated with increasing obesity severity and to quantify follow-up retention and clinically meaningful weight loss. As a secondary exploratory objective, we also examined how diabetes mellitus (DM) relates to these patterns beyond BMI. Methods: Among 5350 screened adults in the Obesity Clinic database, 2879 eligible individuals were included in the baseline cross-sectional analyses, including a non-obese comparison subgroup with BMI < 30 kg/m2. The longitudinal cohort comprised 730 patients with obesity who returned for regular follow-up and had repeat BIA measurements at least 6 months after baseline. Patients were classified according to BMI and glycemic status. Results: Increasing BMI was associated with higher glucose, HbA1c, uric acid, triglyceride, C-reactive protein, and leukocyte levels and with lower HDL cholesterol. Body composition deterioration was driven predominantly by disproportionate increases in visceral fat score, fat mass, and total fat-to-muscle ratio rather than by parallel gains in muscle compartments. As obesity severity increased, the proportion of patients with diabetes also increased. Only 29.3% of the baseline obesity cohort achieved regular 6-month follow-up, and 79.0% of those followed lost less than 5% of baseline body weight. In age- and sex-adjusted analyses, the most pronounced DM-related body composition differences were observed in the BMI 30–39.9 kg/m2 group, particularly through higher waist-to-height ratio and total fat-to-muscle ratio. Conclusions: This study shows that increasing obesity severity is accompanied by a more adverse metabolic profile and a body composition pattern characterized by greater adiposity. Within this framework, diabetes-related body composition differences were not homogeneous across BMI categories and appeared to be most evident in the BMI 30–39.9 kg/m2 group. The weaker association observed in the BMI ≥ 40 kg/m2 group may be related to the reduced discriminative value of waist-based measures in severe obesity, where fat accumulation may extend across multiple compartments. Given the low continuity of follow-up and the limited rates of clinically meaningful weight loss, these findings support a more refined phenotyping approach in obesity management that incorporates body composition and fat distribution in addition to BMI.